Europe's landmark meeting in Gynaecological Oncology, European Society of Gynaecological Oncology (ESGO) 2021, offers professionals a unique opportunity to learn and discuss the latest late-breaking research, new guidelines, practical demonstrations and more.

ESGO 2021

23–25 October 2021 | Prague, Czech Republic

🎥 @GeorgetteOni of NHS Nottingham Breast Institute talks on supporting future generations of healthcare professionals

Watch: 👉http://ow.ly/LwxB50LQ3p0👈

@UKONSmember #UKONS2022 #Nursing #OncologyNursing

"As an oncology community, we must rise to the task today of laying the foundations for sustainable, high-quality #CancerCare that will remain accessible tomorrow", @peters_solange said at the Opening Ceremony for #ESMOAsia22.
👉http://ow.ly/XAbU50LTahQ

🧐TOPAZ-1➡️685 patients.
👇🏾Biomarker analysis👇🏾441 patients.
🛑244 (35.6%)‼️ testing NOT completed?

IDH1 8.8%
HER2 7.9%
FGFR2 3.4%
BRAF 3.6%
BRCA 4.3%
More realistic of real🌍numbers in 1st line.

💡upfront #ctDNA✅ 💯 ➡️you’ll find more. @OncoAlert @curecc #ESMOAsia22 @myESMO https://twitter.com/jdekervel/status/1598599792749600770

Jeroen Dekervel@JDekervel

Impact of molecular driver in #cholangiocarcinoma regarding #durvalumab benefit in #TOPAZ1. Exploratory but some signal for 🔽 efficacy in ERBB2 amp and IDH1mt and 🔼 efficacy in KRASmt. #ESMOAsia22 2

#SABCS22 starts in only a couple of days!

Stay tuned right here 👉http://VJOncology.com👈 which will be updated soon on all the latest in #BreastCancer 👩‍⚕‍🎥🎙

@VJOncology @SABCSSanAntonio @AACR #BreastCancer #BCsm #OncoAlert

Great comprehensive presentation by super @RebeccaDSing at #ESMOasia22 on #immunotherapy in early triple-negative #BreastCancer: important citation for the recent review by @ElisaAgostinett & the great algorithm for #TNBC treatment by @hoperugo

@OncoAlert @myESMO #bcsm #ImmOnc

4
Load More

ESGO 2021

23–25 October 2021 | Prague, Czech Republic
Europe's landmark meeting in Gynaecological Oncology, European Society of Gynaecological Oncology (ESGO) 2021, offers professionals a unique opportunity to learn and discuss the latest late-breaking research, new guidelines, practical demonstrations and more.

🎥 @GeorgetteOni of NHS Nottingham Breast Institute talks on supporting future generations of healthcare professionals

Watch: 👉http://ow.ly/LwxB50LQ3p0👈

@UKONSmember #UKONS2022 #Nursing #OncologyNursing

"As an oncology community, we must rise to the task today of laying the foundations for sustainable, high-quality #CancerCare that will remain accessible tomorrow", @peters_solange said at the Opening Ceremony for #ESMOAsia22.
👉http://ow.ly/XAbU50LTahQ

🧐TOPAZ-1➡️685 patients.
👇🏾Biomarker analysis👇🏾441 patients.
🛑244 (35.6%)‼️ testing NOT completed?

IDH1 8.8%
HER2 7.9%
FGFR2 3.4%
BRAF 3.6%
BRCA 4.3%
More realistic of real🌍numbers in 1st line.

💡upfront #ctDNA✅ 💯 ➡️you’ll find more. @OncoAlert @curecc #ESMOAsia22 @myESMO https://twitter.com/jdekervel/status/1598599792749600770

Jeroen Dekervel@JDekervel

Impact of molecular driver in #cholangiocarcinoma regarding #durvalumab benefit in #TOPAZ1. Exploratory but some signal for 🔽 efficacy in ERBB2 amp and IDH1mt and 🔼 efficacy in KRASmt. #ESMOAsia22 2

#SABCS22 starts in only a couple of days!

Stay tuned right here 👉http://VJOncology.com👈 which will be updated soon on all the latest in #BreastCancer 👩‍⚕‍🎥🎙

@VJOncology @SABCSSanAntonio @AACR #BreastCancer #BCsm #OncoAlert

Great comprehensive presentation by super @RebeccaDSing at #ESMOasia22 on #immunotherapy in early triple-negative #BreastCancer: important citation for the recent review by @ElisaAgostinett & the great algorithm for #TNBC treatment by @hoperugo

@OncoAlert @myESMO #bcsm #ImmOnc

4
Load More

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter